🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess the ocular comfort and safety of olo...
Status
Completed
Location
Multiple Locations
Start Date
2011-04
Trial ID
NCT01326858
Qlaris Phase 2 clinical study investigating the safety, tolerability, and o...
Status
Completed
Location
Berkeley Eye Center
Start Date
2024-04-21
Trial ID
NCT06249152
Treatments Being Tested
A multicenter randomized controlled trial on prevention and treatment of oc...
Status
Unknown
Location
Yingli Li
Start Date
2018-06
Trial ID
NCT03515187
The TRANQUILITY Trial: Multi-Center Randomized, Double-Masked, Parallel Des...
Status
Completed
Location
University Clinical Health
Start Date
2020-11-21
Trial ID
NCT04674358
Treatments Being Tested
This study will examine the efficacy and safety of tivanisiran sodium eye d...
Status
Completed
Location
Sylentis Investigative Site
Start Date
2021-05-25
Trial ID
NCT04819269
Treatments Being Tested
Sjögren's syndrome is a condition in which the immune system attacks the bo...
Status
Not Yet Recruiting
Location
Instituto de Oftalmología Conde de Valenciana
Start Date
2026-12
Trial ID
NCT07671222
Treatments Being Tested
Phase 3 study to evaluate the extended safety of RVL-1201 compared to place...
Status
Completed
Location
Barnet, Dulany Perkins
Start Date
2018-06-20
Trial ID
NCT03536949
Treatments Being Tested
The purpose of this study is to determine the safety of Nevanac 0.1% compar...
Status
Completed
Location
Contact Alcon for Trial Locations
Start Date
2006-02
Trial ID
NCT00332774
This is a multicenter, double-masked study to evaluate the use of Topical O...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-04
Trial ID
NCT07412496
The purpose of this study is to evaluate the effect of Azasite on patients ...
Status
Withdrawn
Location
Philadelphia Eye Associates
Start Date
2013-03
Trial ID
NCT01797107
Treatments Being Tested